136 related articles for article (PubMed ID: 31471646)
21. Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency.
Fojas EGF; Radha SK; Ali T; Nadler EP; Lessan N
Front Endocrinol (Lausanne); 2021; 12():792354. PubMed ID: 35095762
[TBL] [Abstract][Full Text] [Related]
22. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study.
Goulding A; Jones IE; Taylor RW; Williams SM; Manning PJ
J Pediatr; 2001 Oct; 139(4):509-15. PubMed ID: 11598596
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
van der Sluis IM; Boot AM; Hop WC; De Rijke YB; Krenning EP; de Muinck Keizer-Schrama SM
Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
[TBL] [Abstract][Full Text] [Related]
26. GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.
Iepsen EW; Lundgren JR; Hartmann B; Pedersen O; Hansen T; Jørgensen NR; Jensen JE; Holst JJ; Madsbad S; Torekov SS
J Clin Endocrinol Metab; 2015 Aug; 100(8):2909-17. PubMed ID: 26043228
[TBL] [Abstract][Full Text] [Related]
27. Melanocortin-4 Receptor Gene Mutations in a Group of Turkish Obese Children and Adolescents.
Tunç S; Demir K; Tükün FA; Topal C; Hazan F; Sağlam B; Nalbantoğlu Ö; Yıldız M; Özkan B
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):216-221. PubMed ID: 28218067
[TBL] [Abstract][Full Text] [Related]
28. Estimates of volumetric bone density from projectional measurements improve the discriminatory capability of dual X-ray absorptiometry.
Jergas M; Breitenseher M; Glüer CC; Yu W; Genant HK
J Bone Miner Res; 1995 Jul; 10(7):1101-10. PubMed ID: 7484286
[TBL] [Abstract][Full Text] [Related]
29. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence of melanocortin 4 receptor (MC4R) mutations and polymorphismsin consecutively ascertained obese children and adolescents from a pediatric health care utilization population].
Zakel UA; Wudy SA; Heinzel-Gutenbrunner M; Görg T; Schäfer H; Gortner L; Blum WF; Hebebrand J; Hinney A
Klin Padiatr; 2005; 217(4):244-9. PubMed ID: 16032553
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of pathogenetic MC4R mutations in Italian children with early onset obesity, tall stature and familial history of obesity.
Santoro N; Cirillo G; Xiang Z; Tanas R; Greggio N; Morino G; Iughetti L; Vottero A; Salvatoni A; Di Pietro M; Balsamo A; Crinò A; Grandone A; Haskell-Luevano C; Perrone L; del Giudice EM
BMC Med Genet; 2009 Mar; 10():25. PubMed ID: 19284607
[TBL] [Abstract][Full Text] [Related]
33. Extensive BMI Gain in Puberty is Associated with Lower Increments in Bone Mineral Density in Estonian Boys with Overweight and Obesity: A 3-Year Longitudinal Study.
Mengel E; Tillmann V; Remmel L; Kool P; Purge P; Lätt E; Jürimäe J
Calcif Tissue Int; 2017 Aug; 101(2):174-181. PubMed ID: 28374175
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the Impact of Common Polymorphisms of the FTO and MC4R Genes with the Risk of Severe Obesity in Saudi Arabian Population.
Cyrus C; Ismail MH; Chathoth S; Vatte C; Hasen M; Al Ali A
Genet Test Mol Biomarkers; 2018 Mar; 22(3):170-177. PubMed ID: 29466028
[TBL] [Abstract][Full Text] [Related]
35. Influence of the weight status on bone mineral content and bone mineral density in a group of Lebanese adolescent girls.
El Hage R; Jacob C; Moussa E; Groussard C; Pineau JC; Benhamou CL; Jaffré C
Joint Bone Spine; 2009 Dec; 76(6):680-4. PubMed ID: 19945325
[TBL] [Abstract][Full Text] [Related]
36. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.
Valette M; Bellisle F; Carette C; Poitou C; Dubern B; Paradis G; Hercberg S; Muzard L; Clément K; Czernichow S
Int J Obes (Lond); 2013 Aug; 37(8):1027-35. PubMed ID: 23147118
[TBL] [Abstract][Full Text] [Related]
37. Professional football (soccer) players have a markedly greater skeletal mineral content, density and size than age- and BMI-matched controls.
Wittich A; Mautalen CA; Oliveri MB; Bagur A; Somoza F; Rotemberg E
Calcif Tissue Int; 1998 Aug; 63(2):112-7. PubMed ID: 9685514
[TBL] [Abstract][Full Text] [Related]
38. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene.
Reinehr T; Hebebrand J; Friedel S; Toschke AM; Brumm H; Biebermann H; Hinney A
Obesity (Silver Spring); 2009 Feb; 17(2):382-9. PubMed ID: 18997677
[TBL] [Abstract][Full Text] [Related]
39. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.
Takahashi Y; Minamitani K; Kobayashi Y; Minagawa M; Yasuda T; Niimi H
J Clin Endocrinol Metab; 1996 Mar; 81(3):1248-53. PubMed ID: 8772607
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany.
Hinney A; Bettecken T; Tarnow P; Brumm H; Reichwald K; Lichtner P; Scherag A; Nguyen TT; Schlumberger P; Rief W; Vollmert C; Illig T; Wichmann HE; Schäfer H; Platzer M; Biebermann H; Meitinger T; Hebebrand J
J Clin Endocrinol Metab; 2006 May; 91(5):1761-9. PubMed ID: 16492696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
